Renaissance Technologies’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Buy |
17,366
+16,696
| +2,492% | +$31.7K | ﹤0.01% | 3433 |
|
|
2025
Q1 | $4.75K | Buy |
+670
| New | +$4.75K | ﹤0.01% | 3401 |
|
|
2023
Q2 | – | Sell |
-336
| Closed | -$9K | – | 4317 |
|
|
2023
Q1 | $9K | Sell |
336
-2,824
| -89% | -$75.6K | ﹤0.01% | 3894 |
|
|
2022
Q4 | $94K | Sell |
3,160
-4,913
| -61% | -$146K | ﹤0.01% | 3641 |
|
|
2022
Q3 | $414K | Buy |
8,073
+867
| +12% | +$44.5K | ﹤0.01% | 3040 |
|
|
2022
Q2 | $209K | Buy |
7,206
+1,436
| +25% | +$41.6K | ﹤0.01% | 3634 |
|
|
2022
Q1 | $303K | Buy |
5,770
+1,194
| +26% | +$62.7K | ﹤0.01% | 3470 |
|
|
2021
Q4 | $314K | Buy |
4,576
+563
| +14% | +$38.6K | ﹤0.01% | 3321 |
|
|
2021
Q3 | $637K | Sell |
4,013
-343
| -8% | -$54.4K | ﹤0.01% | 2783 |
|
|
2021
Q2 | $850K | Sell |
4,356
-845
| -16% | -$165K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $1.34M | Sell |
5,201
-213
| -4% | -$55K | ﹤0.01% | 2466 |
|
|
2020
Q4 | $1.04M | Buy |
5,414
+213
| +4% | +$41.1K | ﹤0.01% | 2479 |
|
|
2020
Q3 | $1.06M | Buy |
5,201
+1,773
| +52% | +$360K | ﹤0.01% | 2489 |
|
|
2020
Q2 | $959K | Buy |
3,428
+1,633
| +91% | +$457K | ﹤0.01% | 2561 |
|
|
2020
Q1 | $538K | Sell |
1,795
-316
| -15% | -$94.7K | ﹤0.01% | 2729 |
|
|
2019
Q4 | $678K | Buy |
+2,111
| New | +$678K | ﹤0.01% | 2788 |
|